Kither Biotech
Biopharmaceutical company developing novel therapies for rare respiratory diseases
Kither Biotech has raised €19M across 1 funding round from 9 investors, most recently a Series B round in Mar 2022. Based in Turin, Italy; active in Healthtech. Data as of 28 Oct 2026.
Turin, Italy
Total raised
€19M
€18,500,000
Funding rounds
1
Investors
9
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearKither Biotech — funding by year — interactive chart.
Data table
| Kither Biotech — funding by year | |
|---|---|
| 2022 | €19M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-29 | Series B | €19M | 2Invest,3B Future Health Fund,ACE & Company,Alef 6,CDP Venture Capital,Claris Ventures+3 more | View deal → |
Investors
9Related news
- Kither Biotech Raises €18.5M in Series B Fundingfinsmes.com · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData